Samaras Katherine, Lutgers Helen L, Kochan Nicole A, Crawford John D, Campbell Lesley V, Wen Wei, Slavin Melissa J, Baune Bernard T, Lipnicki Darren M, Brodaty Henry, Trollor Julian N, Sachdev Perminder S
Diabetes and Obesity Program, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia,
Age (Dordr). 2014 Apr;36(2):977-93. doi: 10.1007/s11357-013-9613-0. Epub 2014 Jan 9.
Type 2 diabetes predicts accelerated cognitive decline and brain atrophy. We hypothesized that impaired fasting glucose (IFG) and incident glucose disorders have detrimental effects on global cognition and brain volume. We further hypothesized that metabolic and inflammatory derangements accompanying hyperglycaemia contribute to change in brain structure and function. This was a longitudinal study of a community-dwelling elderly cohort with neuropsychological testing (n = 880) and brain volumes by magnetic resonance imaging (n = 312) measured at baseline and 2 years. Primary outcomes were global cognition and total brain volume. Secondary outcomes were cognitive domains (processing speed, memory, language, visuospatial and executive function) and brain volumes (hippocampal, parahippocampal, precuneus and frontal lobe). Participants were categorised as normal, impaired fasting glucose at both assessments (stable IFG), baseline diabetes or incident glucose disorders (incident diabetes or IFG at 2 years). Measures included inflammatory cytokines and oxidative metabolites. Covariates were age, sex, education, non-English speaking background, smoking, blood pressure, lipid-lowering or antihypertensive medications, mood score, apolipoprotein E genotype and baseline cognition or brain volume. Participants with incident glucose disorders had greater decline in global cognition and visuospatial function compared to normal, similar to that observed in baseline diabetes. Homocysteine was independently associated with the observed effect of diabetes on executive function. Apolipoprotein E genotype did not influence the observed effects of diabetes on cognition. Incident glucose disorders and diabetes were also associated with greater 2-year decline in total brain volume, compared to normal (40.0 ± 4.2 vs. 46.7 ± 5.7 mm(3) vs. 18.1 ± 6.2, respectively, p < 0.005). Stable IFG did not show greater decline in global cognition or brain volumes compared to normal. Incident glucose disorders, like diabetes, are associated with accelerated decline in global cognition and brain volumes in non-demented elderly, whereas stable IFG is not. Preventing deterioration in glucose metabolism in the elderly may help preserve brain structure and function.
2型糖尿病预示着认知能力加速衰退和脑萎缩。我们假设空腹血糖受损(IFG)和新发血糖紊乱对整体认知和脑容量有不利影响。我们进一步假设,高血糖伴随的代谢和炎症紊乱会导致脑结构和功能的改变。这是一项针对社区老年队列的纵向研究,在基线和2年时进行了神经心理学测试(n = 880)以及通过磁共振成像测量脑容量(n = 312)。主要结局是整体认知和全脑体积。次要结局是认知领域(处理速度、记忆、语言、视觉空间和执行功能)和脑容量(海马体、海马旁回、楔前叶和额叶)。参与者被分类为正常、两次评估时均空腹血糖受损(稳定IFG)、基线糖尿病或新发血糖紊乱(2年时新发糖尿病或IFG)。测量指标包括炎性细胞因子和氧化代谢产物。协变量包括年龄、性别、教育程度、非英语背景、吸烟、血压、降脂或降压药物、情绪评分、载脂蛋白E基因型以及基线认知或脑容量。与正常参与者相比,新发血糖紊乱的参与者在整体认知和视觉空间功能方面下降更大,类似于在基线糖尿病中观察到的情况。同型半胱氨酸与糖尿病对执行功能的观察效应独立相关。载脂蛋白E基因型并未影响糖尿病对认知的观察效应。与正常参与者相比,新发血糖紊乱和糖尿病还与2年时全脑体积的更大下降相关(分别为40.0±4.2 vs. 46.7±5.7 mm³ vs. 18.1±6.2,p < 0.005)。与正常参与者相比,稳定IFG在整体认知或脑容量方面并未显示出更大下降。新发血糖紊乱与糖尿病一样,与非痴呆老年人的整体认知和脑容量加速下降相关,而稳定IFG则不然。预防老年人葡萄糖代谢恶化可能有助于保护脑结构和功能。